ANHUI HONGYU WUZHOU MEDICAL MANUFACTURER CO.,LTD. Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. Stock
Equities
301234
CNE100005GW5
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.54 CNY | -0.14% |
|
-1.69% | -36.42% |
| Sales 2022 | 547M 75.36M 103M | Sales 2023 | 534M 73.51M 101M | Capitalization | 2.3B 317M 435M |
|---|---|---|---|---|---|
| Net income 2022 | 70M 9.64M 13.2M | Net income 2023 | 60M 8.26M 11.32M | EV / Sales 2022 | 2.97 x |
| Net cash position 2022 | 364M 50.16M 68.7M | Net cash position 2023 | 346M 47.7M 65.32M | EV / Sales 2023 | 3.67 x |
| P/E ratio 2022 |
24.6
x | P/E ratio 2023 |
38.2
x | Employees | 892 |
| Yield 2022 |
1.71% | Yield 2023 |
1.18% | Free-Float | 25.85% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.14% | ||
| 1 week | -1.69% | ||
| Current month | -9.08% | ||
| 1 month | -11.65% | ||
| 3 months | -20.37% | ||
| 6 months | -36.03% | ||
| Current year | -36.42% |
1 week
21.12
22.39
1 month
19.9124.71
Current year
17.0134.44
1 year
17.0154.80
3 years
17.0154.80
5 years
17.0154.80
10 years
17.0154.80
| Managers | Title | Age | Since |
|---|---|---|---|
Hong Yu Zhang
CEO | Chief Executive Officer | 56 | 15-11-30 |
Yu Ji
DFI | Director of Finance/CFO | 35 | 18-05-31 |
Guo Ying Wu
CHM | Chairman | 48 | 11-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Qing Gang Wang
BRD | Director/Board Member | 54 | 23-02-09 |
Fan Huang
CHM | Chairman | 55 | 15-11-30 |
Hong Yu Zhang
CEO | Chief Executive Officer | 56 | 15-11-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-21 | 21.54 | -0.14% | 557,700 |
| 24-06-20 | 21.57 | -2.22% | 850,797 |
| 24-06-19 | 22.06 | +0.27% | 531,800 |
| 24-06-18 | 22 | +2.23% | 652,800 |
| 24-06-17 | 21.52 | -1.78% | 754,400 |
End-of-day quote Shenzhen S.E., June 20, 2024
More quotes
ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd, formerly Anhui Hongyu Wuzhou Medical Manufacturer Co Ltd, is a China-based company mainly engaged in the research and development, production and sales of disposable sterile infusion medical devices. The Company is also engaged in the integrated supply of other diagnostic, nursing and other related medical supplies. The Company's main products include syringes, blood infusion sets, medical puncture needles, blood pressure monitors, masks, catheters and other medical supplies related to diagnosis and nursing. Its products are mainly used in clinical injection, blood transfusion and other treatments.
Calendar
2024-08-25
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -36.42% | 202M | |
| +9.48% | 27.22B | |
| +26.67% | 2.48B | |
| -48.75% | 2.28B | |
| +11.47% | 2.32B | |
| -30.39% | 2.09B | |
| +25.56% | 1.92B | |
| -12.67% | 1.84B | |
| +4.47% | 1.31B | |
| +22.33% | 1.27B |
- Stock Market
- Equities
- 301234 Stock
